Overview

Study of Treatment Used for Migraine Headaches (MK-0974-076)

Status:
Terminated
Trial end date:
2012-03-23
Target enrollment:
Participant gender:
Summary
This study will describe the reasons for triptan utilization patterns (continuation and discontinuation) in triptan-naïve participants and assess the stability of treatment utilization patterns over time according to standard medical guidelines or clinical practice standards of the investigating physician.
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.